EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Of amyloid and inflammation: causes of chronic muscle disease

J. Schmidt

e-Neuroforum · 2010

DOI: 10.1007/s13295-010-0010-1 ↗
AbstractBibliografische Angaben

Abstract

Abstract Classic inflammatory diseases of the skel­etal muscle such as polymyositis and der­matomyositis often lead to rapid weaken­ing of the arm and leg muscles. Inflamma­tion in the muscle is caused primarily by im­mune cells and antibodies. Most patients re­spond well to standard immunosuppressive therapy. In sporadic inclusion body myositis (sIBM), similar pathomechanisms play a role, including cytotoxic T-lymphocytes, which at­tack and damage muscle fibers. At the same time, sIBM is characterized by an accumula­tion of aberrant molecules, particularly β-am­yloid, which play a role in neurodegenera­tive diseases. This degeneration with forma­tion of inclusion bodies and vacuoles may be the cause of the slow yet relentlessly progres­sive damage to the skeletal muscle and the lack of treatment efficacy of standard immu­nosuppression. Recent reports demonstrate that there is a specific interrelationship be­tween inflammation with generation of me­diators such as interleukin (IL)-1β and the amyloid-associated degeneration. The molec­ular mechanisms discussed here are impor­tant for the future design of better treatment strategies for chronic muscle inflammation. Furthermore, these mechanisms can contrib­ute to a better understanding of the patho­genesis of neurodegenerative diseases.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →